Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3062% above fair value
$105.43−1.68 (-1.57%)
Close on Nov 17, 2026Market cap $60.77BP/E 60.6Yield –
Edwards Lifesciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Edwards Lifesciences's pe ratio was 60.8× on Nov 11, 2026, against 37.4× a year earlier. Over the last 5 years it ranged from 10.3× to 60.8×, with a median of 35.1×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 60.8× | +24.1 |
| 2025 | Dec 31, 2025 | 36.7× | +26.1 |
| 2024 | Dec 31, 2024 | 10.7× | −21.9 |
| 2023 | Dec 29, 2023 | 32.6× | +0.4 |
| 2022 | Dec 30, 2022 | 32.2× | −23.0 |
| 2021 | Dec 31, 2021 | 55.1× | −17.9 |
| 2020 | Dec 31, 2020 | 73.0× | +8.7 |
| 2019 | Dec 31, 2019 | 64.3× | +18.3 |
| 2018 | Dec 31, 2018 | 46.0× | +13.2 |
| 2017 | Dec 29, 2017 | 32.8× | −4.3 |
| 2016 | Dec 30, 2016 | 37.0× | −0.4 |
| 2015 | Dec 31, 2015 | 37.4× | +19.8 |
| 2014 | Dec 31, 2014 | 17.6× | −1.1 |
| 2013 | Dec 31, 2013 | 18.8× | −21.6 |
| 2012 | Dec 31, 2012 | 40.4× | +4.7 |
| 2011 | Dec 30, 2011 | 35.7× | −12.4 |
| 2010 | Dec 31, 2010 | 48.1× | +8.6 |
| 2009 | Dec 31, 2009 | 39.5× | – |
See a number that looks wrong?